TB Alliance releases Report on Economics of TB Drugs
The TB Alliance released its newest publication, Economics of TB Drug Development, which is the first analysis of the TB
The TB Alliance released its newest publication, Economics of TB Drug Development, which is the first analysis of the TB
PARIS, Nov. 14 — Trying to entice major drug companies into plunging into the tuberculosis market, the new Global Alliance
In other health news: Trying to entice major drug companies into plunging into the tuberculosis market, the new Global Alliance
A nonprofit health group will issue a report today designed to enlist drug makers in the fight against tuberculosis, a
According to a new Global Alliance for TB Drugs Development report, the anti-tuberculosis drug market could reach $700 million by
Third-world health activists and the global pharmaceutical industry remain sharply at odds over the role of drug patents and price
NEW YORK (Reuters Health) – In a bid to promote industry interest in tuberculosis (TB) drugs, non-profit group the Global
In other health news: Trying to entice major drug companies into plunging into the tuberculosis market, the new Global Alliance
A nonprofit health group will issue a report Thursday designed to enlist drug makers in the fight against tuberculosis, a
Les maladies infectieuses constituent aujourd’hui la principale cause de mortalité dans le monde avec 17 millions de victimes chaque année.